in this issue
People & Business :: Companies
Syngenta delists Devgen following squeeze-out process
10:46 AM MST | February 27, 2013 | Francinia Protti-Alvarez
Syngenta has delisted hybrid rice and RNA technology firm Devgen (Ghent, Belgium) from the NYSE Euronext Brussels exchange, the company announced today. Syngenta secured 94% of the shares of Devgen last December during a €403-million ($526.7 million) public takeover bid. The original deal had been announced in September 2012. Syngenta, following a squeeze-out process that closed yesterday, holds 100% of Devgen's shares. Prior to the opening of the squeeze-out on 6 February, 98.32% of Devgen shares had been tendered to Syngenta. Payment for the shares and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee